🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
456
$4568.T
🔒 Asia-PacificDAIICHI SANKYO COMPANY LIMITED
📅 Next Catalyst: Oct 30, 2026 (☀️ Open) 🏛️ TOKYO STOCK EXCHANGE
📁 Healthcare
🏭 Drug Manufacturers – General
AVG HISTORICAL GAP
+0.11%
MAX GAP RECORD
-5.35%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $4568.T
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$4568.T
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 30, 2026 Earnings Release 2026-10-30 (BEFORE OPEN) | 🔮 UPCOMING 🔒 |
| Jul 31, 2026 Earnings Release 2026-07-31 (BEFORE OPEN) |
-4.67%
|
| May 11, 2026 Earnings Release 2026-05-11 (AFTER CLOSE) |
+2.98%
|
| Jan 30, 2026 Earnings Release 2026-01-30 (AFTER CLOSE) |
+3.42%
|
| Oct 31, 2025 Earnings Release 2025-10-31 (BEFORE OPEN) |
+1.33%
|
| Jul 31, 2025 Earnings Release 2025-07-31 (BEFORE OPEN) |
+0.27%
|
| Apr 24, 2025 Earnings Release 2025-04-24 (AFTER CLOSE) |
+0.15%
|
| Jan 31, 2025 Earnings Release 2025-01-31 (AFTER CLOSE) |
-5.35%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.2%
Bullish Gaps (6)
Bearish Gaps (5)
Neutral / Flat (4)
📖 Intelligence Summary
Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan and internationally. The company offers Enhertu for the treatment of HER2 positive and low breast cancer, HER2 positive gastric or gastroesophageal junction adenocarcinoma, and HER2 positive solid tumors; Turalio, an oral small molecule for colony stimulating factor 1 receptor,…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗